RNU6-120P

Across TCGA pan-cancer cohorts, RNU6-120P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-120P data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RNU6-120P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-120P expression acts as an unfavorable survival marker, although some lineages such as SARC show a favorable association.

KICH, CESC, and TGCT are the cancer types where RNU6-120P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	All	0.082	0.877	<.001	78	view →
CESC	OS	Tertile	All	0.242	0.798	.003	72	view →
TGCT	DFS	Tertile	All	0.064	0.813	<.001	36	view →
SKCM	DFS	Tertile	All	0.177	0.728	.010	24	view →
PAAD	OS	Tertile	II,III,IV	0.213	0.556	.014	18	view →
STAD	DFS	Tertile	All	0.506	0.725	.041	9	view →
THYM	DFS	Tertile	All	0.400	0.788	.013	6	view →
SARC	OS	Tertile	All	1.000	0.498	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-120P–KICH (OS)

Open the KICH breakdown →